| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.4 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |